The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...

Patients with diabetic macular edema in higher dose cohorts showed a mean BCVA gain of approximately 10 ETDRS letters sustained through 24 weeks after a single intravitreal injection Patients with wet ...

The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...

Sustained, clinically meaningful bilateral improvement in visual functions 96 weeks after injection Observed bilateral improvement interpreted as clearly superior to known natural history Improvements ...

July 15, 2009 — Current evidence is insufficient to determine the balance of benefits and harms of visual acuity screening for the improvement of outcomes in older adults, according to a position ...

Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing in the registrational PIONEER program across 2 key ...

Please provide your email address to receive an email when new articles are posted on . DENVER — Children with amblyopia treated with an at-home device experienced improvement in visual acuity and ...

SAN ANTONIO -- Visual acuity in patients with diabetic macular edema (DME) improved significantly after an early switch to a dexamethasone implant following inadequate response to anti-VEGF therapy, a ...

Digital video games improved visual acuity in children with amblyopia through binocular rehabilitation over 8 weeks. Participants aged 4-12 played games like Tetris and Snake with anaglyphic glasses, ...

There were 26 serious adverse events in 19 participants; 21 (81%) occurred within 2 months after surgery. HealthDay News — In participants with geographic atrophy due to age-related macular ...

Credit: Getty Images. With Luminopia One, patients watch therapeutically modified TV shows and movies to improve their vision within a virtual reality headset. The Food and Drug Administration (FDA) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Visual acuity improvements were sustained through 5 ...